VanEck Associates Portfolio holdings
AUM
$88.3B
1-Year Return
29.35%
This Quarter Return
-4.25%
1 Year Return
+29.35%
3 Year Return
+120.6%
5 Year Return
+164.76%
10 Year Return
+545.37%
AUM
$20.1B
AUM Growth
-$154M
(-0.76%)
Cap. Flow
+$927M
Cap. Flow
% of AUM
4.61%
Top 10 Holdings %
Top 10 Hldgs %
28.47%
Holding
777
New
61
Increased
377
Reduced
301
Closed
33
Top Buys
| 1 |
Newmont
NEM
|
$255M |
| 2 |
Nutrien
NTR
|
$185M |
| 3 |
B
Barrick Mining Corporation
B
|
$169M |
| 4 |
Franco-Nevada
FNV
|
$155M |
| 5 |
GG
Goldcorp Inc
GG
|
$149M |
Top Sells
| 1 |
AGU
Agrium
AGU
|
$169M |
| 2 |
Union Pacific
UNP
|
$63.1M |
| 3 |
POT
Potash Corp Of Saskatchewan
POT
|
$43M |
| 4 |
CPE
Callon Petroleum Company
CPE
|
$38.5M |
| 5 |
Intel
INTC
|
$33M |
Sector Composition
| 1 | Materials | 51.84% |
| 2 | Energy | 17.22% |
| 3 | Healthcare | 6.47% |
| 4 | Technology | 5.7% |
| 5 | Consumer Discretionary | 2.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Guidewire Software
GWRE
$22B
| $16.1M | 0.08% |
198,623
-33,960
| -15% | -$2.75M |
|
202
Vale
VALE
$44.4B
| $16M | 0.08% |
1,261,020
+161,671
| +15% | +$2.06M |
|
|
NE
203
DELISTED
Noble Corporation
NE
| $16M | 0.08% |
4,311,582
+658,072
| +18% | +$2.44M |
|
|
GPL
204
DELISTED
Great Panther Mining Limited
GPL
| $15.6M | 0.08% |
1,336,392
+28,088
| +2% | +$329K |
|
205
Sociedad Química y Minera de Chile
SQM
$13.1B
| $15.6M | 0.08% |
317,338
+25,255
| +9% | +$1.24M |
|
206
Qorvo
QRVO
$8.61B
| $14.9M | 0.07% |
212,122
-1,881
| -0.9% | -$133K |
|
207
Ternium
TX
$6.79B
| $14.6M | 0.07% |
450,435
+56,356
| +14% | +$1.83M |
|
208
Perrigo
PRGO
$3.12B
| $14.5M | 0.07% |
173,996
-8,536
| -5% | -$711K |
|
209
Main Street Capital
MAIN
$5.95B
| $14.5M | 0.07% |
392,447
-18,367
| -4% | -$678K |
|
|
CCT
210
DELISTED
Corporate Capital Trust, Inc.
CCT
| $14.4M | 0.07% |
+849,171
| New | +$14.4M |
|
211
Toro Company
TTC
$7.99B
| $14.3M | 0.07% |
228,945
+14,746
| +7% | +$921K |
|
212
Prospect Capital
PSEC
$1.34B
| $13.4M | 0.07% |
2,052,603
-317,381
| -13% | -$2.08M |
|
213
GSK
GSK
$81.5B
| $13.1M | 0.07% |
268,806
-42,299
| -14% | -$2.07M |
|
|
ANTX
214
DELISTED
Anthem, Inc.
ANTX
| $13M | 0.06% |
242,444
+5,875
| +2% | +$315K |
|
|
CAVM
215
DELISTED
Cavium, Inc.
CAVM
| $13M | 0.06% |
163,738
+11,427
| +8% | +$907K |
|
216
AstraZeneca
AZN
$253B
| $13M | 0.06% |
371,391
-47,799
| -11% | -$1.67M |
|
|
DCUD
217
DELISTED
Dominion Energy, Inc 2016 Series A Corporate Units
DCUD
| $12.6M | 0.06% |
271,537
+6,581
| +2% | +$305K |
|
218
Sanofi
SNY
$113B
| $12.6M | 0.06% |
313,775
+1,575
| +0.5% | +$63.1K |
|
219
Johnson & Johnson
JNJ
$430B
| $12.4M | 0.06% |
97,022
+1,681
| +2% | +$215K |
|
220
Novartis
NVS
$251B
| $12.4M | 0.06% |
170,742
-9,863
| -5% | -$715K |
|
221
Novo Nordisk
NVO
$245B
| $12.2M | 0.06% |
494,554
-21,970
| -4% | -$541K |
|
222
Qiagen
QGEN
$10.3B
| $12M | 0.06% |
350,190
-90,598
| -21% | -$3.1M |
|
|
VEDL
223
DELISTED
Vedanta Limited American Depostary Shares (Each representing four equity shares)
VEDL
| $11.9M | 0.06% |
678,853
+85,208
| +14% | +$1.5M |
|
224
Jazz Pharmaceuticals
JAZZ
$7.86B
| $11.7M | 0.06% |
77,553
-9,366
| -11% | -$1.41M |
|
225
Bausch Health
BHC
$2.72B
| $11.5M | 0.06% |
723,123
+33,987
| +5% | +$541K |
|